J Proteome Res Journal Impact Factor

What Is the Journal of Proteome Research?

If you work in proteomics, biochemistry, or any field that sits at the intersection of biology and chemistry, you've probably heard of J Proteome Res*. It's one of those journals that carries real weight in the scientific community, especially among researchers who study proteins — how they're structured, how they interact, and what they tell us about disease and health.

The journal is published by the American Chemical Society (ACS), which gives it a solid institutional backbone. It's been around since the early 2000s and has grown alongside the proteomics field itself, which has exploded in scope and sophistication over the past couple of decades.

This is the kind of thing that separates good results from great ones.

But here's the thing most people actually want to know: what's its impact factor, and does it matter for your work? That's what this post is really about.

Why the Impact Factor of J Proteome Res Matters

What an Impact Factor Actually Tells You

Before digging into the specifics of this journal, it helps to understand what an impact factor even means — because a lot of researchers treat it like a scoreboard, and that's only partially useful.

An impact factor is a metric calculated by Clarivate Analytics (now part of Web of Science) based on citation counts. Roughly speaking, it measures how often articles from a given journal were cited in a particular year, divided by the number of citable articles published in the two prior years. A higher number generally means the journal's articles are being read, referenced, and built upon more frequently.

That's it. It doesn't measure the quality of any single paper. This leads to it doesn't tell you whether a specific finding is reproducible or significant. It's a snapshot of a journal's visibility and influence within the broader scientific literature.

Why Researchers Pay Attention

For early-career scientists, the impact factor of a target journal can feel like a make-or-break number. Plus, it shows up in hiring committees, grant evaluations, and tenure reviews. For principal investigators deciding where to submit a manuscript, it's one data point among many — but it's often the one that gets discussed first.

For J Proteome Res* specifically, the impact factor matters because it sits in a competitive niche. Proteomics journals have to compete not just with each other but with broader biochemistry and molecular biology journals that attract far more submissions and citations.

How the Impact Factor of J Proteome Res Has Changed Over Time

A Journal That Grew With the Field

The proteomics landscape has shifted dramatically since J Proteome Res* launched. When the field was younger, the journal was one of the few dedicated venues for protein-centric research. That exclusivity gave it a natural advantage — fewer competing journals meant each publication got more attention.

As the field matured, though, more outlets appeared. Worth adding: journals like Molecular & Cellular Proteomics* (also an ACS publication), Proteomics*, and various generalist journals began accepting proteomics work more readily. The competition for citations intensified.

Through all of that, J Proteome Res* has generally maintained a solid standing. It's not the highest-impact journal in the ACS portfolio — journals like Chemical Reviews* or Journal of the American Chemical Society* sit in a different tier entirely — but within its specialized domain, it holds its own.

What the Numbers Suggest

I'm not going to quote a specific impact factor number here because these figures get updated annually and vary depending on which year you look at and which version of the calculation you're using. The Journal Citation Reports (JCR) from Clarivate is the standard source, and the number can shift from year to year based on citation patterns that are partly unpredictable.

What I will say is that the journal's impact factor has generally hovered in a range that reflects its status as a respected, mid-to-upper-tier venue for proteomics research. And it's not a fly-by-night publication. It's not a mega-journal that publishes everything and rides on volume. It's a selective, peer-reviewed journal with a clear editorial focus.

What Makes J Proteome Res Stand Out

Scope and Specialization

The journal covers a wide range of proteomics topics, including but not limited to:

• Mass spectrometry-based proteomics
• Protein structure and function
• Protein-protein interactions
• Biomarker discovery
• Computational proteomics and bioinformatics
• Clinical and translational proteomics

This breadth is a strength. Researchers working on anything from basic protein biochemistry to clinical applications can find a home in J Proteome Res*, and the editorial team tends to attract submissions that are methodologically rigorous.

The ACS Advantage

Being part of the ACS ecosystem means the journal benefits from the society's reputation, its indexing in major databases, and its distribution channels. Articles published in ACS journals are generally well-indexed in PubMed, Web of Science, and Scopus, which matters for visibility and citation potential.

Peer Review Standards

The peer review process at J Proteome Res* is known to be thorough. Consider this: the journal doesn't accept every submission — acceptance rates are competitive, and reviewers tend to be demanding about methodological rigor, statistical analysis, and the clarity of data interpretation. That selectivity contributes to the journal's reputation over time.

Common Mistakes People Make When Evaluating This Journal

Confusing Impact Factor with Personal Relevance

Here's a trap a lot of researchers fall into: they see a journal's impact factor and assume it automatically makes their work more valuable. It doesn't. But a well-crafted proteomics paper published in a lower-impact journal can be far more influential than a mediocre paper in a high-impact one. Reviewers at top journals reject strong papers all the time — and lower-impact journals sometimes publish work that ends up being cited more because it's genuinely useful.

If you found this helpful, you might also enjoy what causes water molecules to be polar or why is bismuth a 3 ion.

Ignoring the Journal's Audience

J Proteome Res* is read primarily by proteomics researchers, biochemists, and people in adjacent fields. If your work is highly interdisciplinary — say, bridging proteomics and clinical medicine — you might get more traction in a broader journal. Choosing a venue based on impact factor alone, without considering who's actually reading it, is a strategic mistake.

Treating the Impact Factor as Static

Impact factors fluctuate. A journal's number one year might dip the next year for reasons that have nothing to do with the quality of the science — a particularly strong or weak cohort of articles, changes in citation behavior, or shifts in the field's overall publishing patterns. One year's number is a data point, not a verdict.

Practical Tips for Researchers Considering J Proteome Res

Read the Aims and Scope Carefully

Before submitting, make sure your paper fits the journal's stated scope. J Proteome Res* has clear editorial boundaries, and a mismatch between your manuscript and the journal's focus is the fastest way to get desk-rejected. Check the aims and scope on the ACS website and compare them to your abstract.

Look at Recent Issues

Spend some time browsing the latest articles. Because of that, are the papers you're comparing yours to being cited in your own literature review? So naturally, do the papers look like yours in terms of methodology, scope, and depth? This is a more useful exercise than staring at the impact factor number.

Consider the Turnaround Time

Publication timelines matter, especially if you're working on a grant deadline or need results out quickly. J Proteome Res*, like most ACS journals, has a peer review process

Consider the Turnaround Time

Publication timelines matter, especially if you’re working on a grant deadline or need results out quickly. So j Proteome Res* has a peer‑review process that typically takes 4–6 weeks from submission to first decision, but this can stretch if the manuscript requires extensive revisions. If rapid dissemination is a priority, you might want to compare the average review time on the ACS “Journal Metrics” page or ask colleagues who have recently published there for their experience.

Pay Attention to the Editorial Board

A journal’s editorial board can give you advantaged insight into its priorities. If the board includes experts who frequently publish in your sub‑field (e.Practically speaking, , quantitative proteomics, post‑translational modifications, or proteogenomics), you’ll likely see a higher rate of acceptance for papers that align with those interests. Even so, g. Conversely, if the board is dominated by clinicians, a purely technical study may be viewed as outside scope.

Evaluate the Open‑Access Policy

J Proteome Res* offers a hybrid publishing model. Here's the thing — you can opt for immediate open access by paying an Article Processing Charge (APC) or publish under the traditional subscription model. Open‑access articles tend to receive more downloads and sometimes citations, but the APC can be a significant consideration for early‑career researchers or those with limited institutional support.

Look for Special Issues and Thematic Calls

The journal periodically hosts special issues on hot topics—such as single‑cell proteomics, proteomics in neurodegeneration, or mass‑spectrometry workflow standardization. Submitting to a special issue can increase visibility and readership, but it also means your paper will be judged in the context of a curated collection, sometimes with a tighter deadline.

Factor in Your Career Stage

Early‑career researchers may benefit from a journal that is known for fostering new voices. J Proteome Res* has a track record of publishing first‑author papers from graduate students and postdocs, and its editorial policy encourages thorough methodological transparency. Senior scientists, on the other hand, might prefer a venue that is more strictly selective, as the prestige associated with a high impact factor can aid in tenure reviews and grant evaluations.

Understand the Citation Landscape

Even within a single journal, citation patterns can vary widely. This leads to a paper on data‑analysis pipelines may be cited hundreds of times, while a niche methodological note may attract only a handful. Use tools like Scopus or Web of Science to see how many citations the most recent 20–30 articles in J Proteome Res* have accrued. This gives you a realistic expectation of how your work might perform in terms of visibility.

make use of Preprint Servers

Many authors first upload their manuscripts to bioRxiv or ChemRxiv before submitting to J Proteome Res*. Think about it: doing so can establish priority, gather early feedback, and increase the manuscript’s visibility. The journal accepts preprints and even encourages them, so you can still benefit from the peer review process without losing the advantages of early dissemination.

Conclusion

Choosing J Proteome Res* as a publication venue is less about chasing a lofty impact factor and more about aligning your research with the journal’s mission, audience, and editorial expectations. A well‑designed proteomics study that fits within the journal’s scope, addresses the methodological rigor demanded by its reviewers, and resonates with its readership stands a good chance of acceptance and meaningful impact.

Remember that impact factor is a global metric, not a personal guarantee. That's why by focusing on the relevance of your work to the journal’s community, the clarity of your data presentation, and the strategic timing of your submission, you can maximize the reach and influence of your research. Whether you are a seasoned investigator or a graduate student, a thoughtful, audience‑centric approach to journal selection will ultimately serve your scientific goals better than any single number on a citation chart.